Analyst Price Target is $37.00
▲ +72.66% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for SI-BONE in the last 3 months. The average price target is $37.00, with a high forecast of $40.00 and a low forecast of $32.00. The average price target represents a 72.66% upside from the last price of $21.43.
Current Consensus is
The current consensus among 7 polled investment analysts is to buy stock in SI-BONE. This Buy consensus rating has held steady for over two years.
SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.